Trial
NCT03802747
Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
AstraZeneca
Condition
Colorectal Cancer
Intervention
Durvalumab
Why stopped
PI left the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-09